Parvovirus B19 infection in pregnancy;Parvovirus-B19-infektion in der schwangerschaft

Deutsches Arzteblatt

Volumn 103, Issue 43, 2006, Pages

  Modrow, Susanne ^a   Gärtner, Barbara ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Childcare; Erythema infectiosum; Fetal hydrops; Parvovirus B19; Pregnancy

Indexed keywords

ANEMIA; ARTHRALGIA; ARTHRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENCEPHALITIS; ERYTHEMA INFECTIOSUM; FEMALE; HEPATITIS; HUMAN; MYOCARDITIS; PREGNANCY; PREGNANT WOMAN; RASH; REVIEW;

EID: 33751501735     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; ii: 1033-4.
2. Kerr JR, Modrow S: Human and primate parvovirus infections and associated disease. In: Berns K et al., eds: Parvoviruses. London: Edward Arnold (Publishers) Ltd. 2006; 385-416.
3. Enders M, Weidner A, Zoellner I, Searle K, Enders G: Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513-8.
4. Yaegashi N, Okamura K, Yajima A, Murai C, Sugamura K: The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J Perinat Med 1994; 22: 159-63.
5. Public health laboratory service working party on fifth disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990; 300: 1166-70.
6. Gratacos E, Torres PJ, Vidal J et al.: The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171: 1360-3.
7. Koch WC, Harger JH, Barnstein B, Adler SP: Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998; 17: 489-94.
8. Harger JH, Adler SP, Koch WC, Harger GF: Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symtoms. Obstet Gynecol 1998; 91: 413-20.
9. Miller E, Fairley C, Cohen BJ, Seng C: Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynecol 1998; 105: 174-8.
10. Skjoldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Wahren B, Broliden K, Nyman M: Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 2000; 107: 476-80.
11. Skjoldebrand-Sparre L, Fridell E, Nyman M, Wahren B: A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 336-9.
12. Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF: An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000; 107: 637-43.
13. Valeur-Jensen AK, Pedersen CB, Westergaard T et al.: Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999; 281: 1099-105.
14. Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpaa R: Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus 819 infection in South-Western Finland. BJOG 2005; 112: 50-6.
15. Knowles SJ, Grundy K, Cahill I, Cafferkey MT: Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health 2004; 7: 344-8.
16. Karunajeewa H, Siebert D, Hammond R, Garland S, Kelly H: Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust N Z J Obstet Gynaecol 2001; 41: 23-8.
17. Gilbert NL, Gyorkos TW, Beliveau C, Rahme E, Muecke C, Soto JC: Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 2005; 133: 299-304.
18. Gillespie SM, Cartter ML, Asch S et al: Occupational risk of human parvovirus B19 infection for school and day-care personnel during an out-break of erythema infectiosum. JAMA 1990; 263: 2061-5.
19. Cartter ML, Farley TA, Rosengren S et al.: Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis 1991; 163: 282-5.
20. Ziyaeyan M, Rasouli M, Alborzi A: The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran. Jpn J Infect Dis 2005; 58: 95-7.
21. Koch WC, Adler SP: Human parvovirus B19 infections in women of child-bearing age and within families. Pediatr Infect Dis J 1989; 8: 83-7.
22. Noyola DE, Padilla-Ruiz ML, Obregon-Ramos MG, Zayas P, Perez-Romano B: Parvovirus B19 infection in medical students during a hospital outbreak. J Med Microbiol 2004; 53: 141-6.
23. Ray SM, Erdman DD, Berschling JD, Cooper JE, Jorok TJ, Blumberg HM: Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 1997; 18: 109-14,
24. Dowell SF, Török TJ, Thorp JA et al.: Parvovirus B19 infection in hospital workers: community or hospital acquisition? J Infect Dis 1995; 172: 1076-9.
25. Mead PB et al., eds: Protocols for infectious diseases in obstretic. (Protocols in obstretic and gynecology). Oxford: Blackwell Science Ltd. 2000: 171-80.